NCT04563845
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
Clinical trial condition
Lentivirus Infections
Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.
5,643 public trials
304 recruiting studies
Lentivirus Infections trial results
Completed
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.
NCT05489406
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- RTCCS Radboudumc Nijmegen, Netherlands
NCT00144248
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
- Locations
-
- Boehringer Ingelheim Investigational Site Bakersfield, California, United States
- Boehringer Ingelheim Investigational Site San Francisco, California, United States
- California Pacific Medical Center San Francisco, California, United States
- Albany Medical College, MC 142 Albany, New York, United States
NCT03826199
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Gugulethu Midwife Obstetric Unit Cape Town, South Africa
NCT00275444
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
- Living Hope Clinical Trials, Inc. Long Beach, California, United States
- Boehringer Ingelheim Investigational Site Los Angeles, California, United States
NCT00056641
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- Boehringer Ingelheim Investigational Site Berkeley, California, United States
- Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
- Boehringer Ingelheim Investigational Site Los Angeles, California, United States
NCT02486133
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Klinikum rechts der Isar Munich, Germany
NCT02407691
- Conditions
- Acquired Immunodeficiency Syndrome, Behavior, Behavioral Symptoms, +18 more
- Locations
-
- Dr Kenneth Kaunda District Klerksdorp, North West, South Africa
- Bojanala District Rustenburg, North West, South Africa
Completed
Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)
NCT05152953
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Auburn University Harrison School of Pharmacy Auburn, Alabama, United States
- University of California San Francisco School of Pharmacy San Francisco, California, United States
- Nova Southeastern University College of Pharmacy Fort Lauderdale, Florida, United States
- Texas A&M Irma Lerma Rangel College of Pharmacy Kingsville, Texas, United States
NCT03851419
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Central Nervous System Diseases, +25 more
- Locations
-
- National Institute of Medical Research Dar es Salaam, Tanzania